Recherche avancée

Actuellement, Felicia Kantor Hendrix est directrice financière et vice-présidente exécutive de Penn National Gaming, Inc. et directrice générale et analyste de recherche sur les actions chez Barclays Capital, Inc. Dans le passé, elle a occupé le poste d'associée aux ventes d'actions institutionnelles chez Needham & Co. LLC, associée de recherche chez Gerard Klauer Mattison & Co., Inc. et analyste de recherche chez Lehman Brothers, Inc. Elle est titulaire d'un diplôme de premier cycle de l'université de Virginie et d'un MBA de la Darden School of Business de l'université de Virginie.

Jan Hendrix Holsboer is currently the Chairman at Stichting Imtech, Fonds van Hove van Zijll Anno 1647,.
Vithèr Hyperthermia BV, Stichting Phanos Hypo Notes, Yafa SpA, Stichting Pensioenfonds Staples, Stichting Preferente Aandelen Buhrmann NV, Stichting Preferente Aandelen Corporate Express, Yura International BV, and YAM Invest NV.
He is also a Member-Supervisory Board at NN Insurance Eurasia NV.
In the past, Mr. Holsboer served as the Chairman-Supervisory Board at NN Group NV from 2014 to 2019.
He was also the Chairman at Stichting Vie d'Or and Vereniging Pro Senectute.
Additionally, he held positions such as Vice Chairman at Amsterdam Institute of Finance, Chairman-Supervisory Board at TD Bank NV from 2001 to 2018, Chairman-Executive Board at Panorama Mesdag BV, Senior Independent Non-Executive Director at PartnerRe Ltd.
from 2014 to 2016, and Executive Director at ING Groep NV from 1990 to 1999.
He was also a Director at Univar NV, Onderlinge Levensverzekering Maatschappij 's Gravenhage UA, and Stichting Corporate Express NV.
Furthermore, he served as a Member-Supervisory Board at ING Groep NV from 2012 to 2014, Independent Member-Supervisory Board at Delta Lloyd NV in 2011, Member-Executive Board at Nationale Nederlanden NV, Member-Supervisory Board at Atradius NV from 2010 to 2012, Member-Supervisory Board at ING Verzekeringen NV from 2012 to 2014, Member-Supervisory Board at ING Bank NV, Member-Supervisory Board at Atradius Credit Insurance NV, and President at The Geneva Association from 1999 to 1999.

Kimberly A.
Hendrix is currently working as Counsel at Stradley, Ronon, Stevens & Young LLP.
She completed her graduate degree from Duke University in 1995 and her undergraduate degree from Duke University in 1992.

Dave Hendrix is currently working as a Senior Vice President-Strategic Innovation at SailPoint Technologies, Inc. Prior to his current position, he held various roles including Director-Business Development at iXL, Inc., Senior Manager-Marketing at SEI Investments Co., Vice President-Client Services at Kinzan, Inc., Vice President-Services at Convio, Inc., and Senior Consultant at A.T.
Kearney, Inc. He also served as a Member in the US Air Force.

Mr. Cap Hendrix is President & Chief Executive Officer at Tropitone Furniture Co., Inc. Mr. Hendrix was previously employed as a Principal by Culligan International Co., a Principal by Masco Corp., and a Principal by PepsiCo, Inc.

Michelle L.
Hendrix worked as a Principal at Burns International Security Services Corp.
from 2012 to 2013.
She also worked as a Principal at United States Marine Corps from 1996 to 1996.
Additionally, she worked as a Secretary at First Coast Security Solutions, Inc.

Along with her appointment as Senior Advisor for Propel Bio Partners, Suzanne Hendrix is CEO of Pentara Corporation, a boutique CRO in Salt Lake City, Utah, USA specializing in statistics and data management in neurodegenerative diseases.
Under her leadership, Pentara has supported the study design, data collection, and analysis of over 50 clinical trials since 2008.
Ms. Hendrix has more than 30 years of clinical trials experience with time spent at CROs and pharmaceutical companies, including projects across many disease areas including respiratory, oncology, reproductive, and cardiovascular.
She has been instrumental in analysis and reporting for multiple regulatory submissions including NDAs, PLAs, and ISS/ISE documents.
Ms. Hendrix has first authored or co-authored over 150 peer-reviewed publications related to both clinical trial results and statistical approaches for clinical trials, most of which relate to analysis and design of trials for neurodegenerative diseases.
She has extensive experience in optimally measuring progression over time and identifying outcomes that are likely to be sensitive to effects due to treatments that modify important aspects of the disease.
Ms. Hendrix received her PhD from Boston University working with Ralph D’Agostino, a well-respected statistical consultant for the FDA, editor of Statistics in Medicine and Fellow of the American Statistical Association.
She has recently been involved with the World Health Organization in a collaboration to develop an intrinsic capacity score to measure the maintenance of health at older ages.

Glenn P.
Hendrix is currently the Chairman at Arnall Golden Gregory LLP and Director at Metro Atlanta Chamber of Commerce.

Ren Hendrix has held at least one job in the past, and is currently the Chairman-Supervisory Board at Stichting "AKKOORD!".
primair openbaar.

Christel Hendrix currently works as a Director at Igo BV.

I.
Edgar Hendrix is currently a Director at Cherokee Nation Enterprises LLC.
He was formerly the Chairman at Beta Operating Co. LLC, an Independent Director at Matrix Service Co., a Director at Whitmar Exploration Co., Treasurer & Vice President at Parker Drilling Co., and a Trustee at Cavanal Hill Funds.
He also served as the Chief Financial Officer & Executive Vice President at Loudfire, Inc. and Atlas Pipeline Mid-Continent LLC.
Additionally, he was the President of Patriot Energy Resources, Inc. from 2005 to 2012.
Hendrix received his undergraduate degree from Oklahoma Christian University and his MBA from the University of Oklahoma.

Dr. Hendrix joined Mellon Equity, now Mellon Capital Management, in 2002.
He was employee of Mellon Financial Corporation in 1996.
Prior to Mellon, Dr. Hendrix was a Risk Analyst at Signet Bank and a Software Engineer for the Inter-National Research Institute in Newport News at Virginia.
Dr. Hendrix earned a BS in Electrical and Computer Engineering form Clemson University, PhD in Electrical and Computer Engineering from Carnegie Mellon University and an MBA from Carnegie Mellon University with concentrations in Finance and Strategy.
He is a member of the Pittsburgh Society of Financial Analysts and the CFA Institute.

Richard J.
Hendrix is the founder of Live Oak Merchant Partners LLC (founded in 2019) and.
Rjh Management Co. Llc (founded in 2017), where he holds the titles of Managing Partner and Chief Executive Officer respectively.
He currently holds the position of Chief Executive Officer & Director at Live Oak Mobility Acquisition Corp.
and Live Oak Crestview Climate Acquisition Corp.
He also serves as Chairman at Flint Hill School, Advanced Marketing & Processing, Inc., and PMC Consolidated Holdings LLC.
Additionally, he is the Executive Chairman at Danimer Scientific, Inc. since 2020 and a Director at America's Lift Chairs LLC since 2020.
Mr. Hendrix is an Independent Director at Navitas Semiconductor Corp.
and an Operating Executive at Crestview Advisors LLC.
He is also an Operating Partner at Crestview Partners LP and a Managing Member at Live Oak Mobility Sponsor Partners LLC.
In his former positions, Mr. Hendrix served as Chairman & Chief Executive Officer at FBR Investment Management, Inc., President & Chief Executive Officer at FBR Capital Markets & Co. (Old), Chairman, President & Chief Executive Officer at FBR & Co., Chief Executive Officer & Director at Live Oak Acquisition Corp., and Chief Executive Officer & Director at Live Oak Acquisition Corp.
II.
He was also a Director at B.
Riley Financial, Inc. in 2017.
Prior to that, he held the position of Managing Director at PNC Capital Markets LLC from 1987 to 1999.
Mr. Hendrix was President & Chief Operating Officer at Arlington Asset Investment Corp.
from 2003 to 2007 and President & Chief Operating Officer at FBR Asset Investment Corp.
from 1999 to 2003.
He obtained his undergraduate degree from the University of Miami in 1987.

Megan Hendrix is currently the Chief Operating Officer at Honor Credit Union.
She completed her undergraduate degree at Capella University LLC.

Alisa Hendrix currently works as a Director at Indiana University Foundation, Inc.

Anita E.
Hendrix currently works as a Director at St. Luke's Hospital (Missouri).

Paula Hendrix has worked as a Manager at Thoroughbred Ford, Inc. since 2011.

Michael B.
Hendrix is currently a Director at Dembo Jones PC, a Member at The American Institute of Certified Public Accountants, and a Member at Maryland Association of Certified Public Accountants.
He completed his undergraduate degree at the University of Baltimore.

Mr. Hendrix Vachon is Senior Economist at Desjardins Economics Studies.
Prior to joining Desjardins in March 2006, Mr. Vachon received his graduate degree from the University of Sherbrooke in 2005.

Cathlene J.
Hendrix worked as a VP & Manager-Small Business Administration at Bank of the Cascades.

F.E.
Hendrix currently works at Laurens Electric Cooperative, Inc., as Vice Chairman.

Blair Hendrix has held trustee positions at New England Conservatory of Music and Dana Hall Schools.

Parker J.
Hendrix worked as an Analyst at Lariat Partners LP from 2013 to 2019 and as a Portfolio Management Associate at Morgan Stanley Smith Barney Private Management LLC in 2012.
He completed his undergraduate degree at Colorado State University and earned an MBA from the University of Denver.

Mary J.
C.
Hendrix is currently the Chairman at the National Disease Research Interchange.
She is also the Director at Research!America, the Annenberg Center for Health Sciences at Eisenhower, and the Chicago Council On Science & Technology.

Anthony S.
Hendrix currently works at American Vanguard Corp., as Senior Vice President-US & Canada Sales from 2018.

Gary Hendrix currently works at Co-Alliance Cooperative, Inc., as Director.

Elke Hendrix has worked as a Director at Visa Belgium CVBA since 2018.

Steve Hendrix currently works at United Community Bank of West Kentucky, Inc., as Director.

Martin Hendrix is currently a Director at Prometheus Laboratories, Inc., Bodymed AG, ProciseDx LLC, and Nestle Health Science SA where he holds the position of Head-Global Business Development & M&A.
In the past, he worked as a Senior Director-Business Strategy at Bayer AG, Director at Enterome SA, Director at Axcella Health, Inc., Independent Director at Prometheus Biosciences, Inc., and Director at Microbiome Diagnostics Partners SA. Dr. Hendrix holds a doctorate from The Scripps Research Institute and a graduate degree from Georgia Institute of Technology.